Filtry
Modern treatment of chronic viral hepatitis C
to current therapeutic combinations of direct acting antivirals (DAA). Introduction of DAA to clinical practice caused literally a revolution in hepatitis C management in chronic hepatitis C treatment usi...
Gastroenterology and hepatology
- 2018 •
- Jost
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Current hepatitis C therapy
with direct acting antivirals (DAA) is almost 100 %. Currently, the main mission...
Infectious Diseases
- 2022 •
- JSC •
- Odkaz
Rok uplatnění
JSC - Článek v periodiku v databázi SCOPUS
Výsledek na webu
Current hepatitis C therapy
Summary: Chronic hepatitis C therapy using directly acting antivirals (DAAs) has high efficacy (up to 100%), minimal contraindications and an extraordinarily favorable safety profile. Current options of interferon-free ther...
Infectious Diseases
- 2018 •
- Jost
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Therapy of chronic hepatitis C using direct-acting antivirals
with direct-acting antivirals (DAA) is almost 100 %. Currently, the main mission...
Infectious Diseases
- 2022 •
- Jost •
- Odkaz
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Výsledek na webu
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
All-oral direct-acting antiviral drugs (DAAs) for hepatitis C virus, which have list price of DAAs has led many governments to restrict their reimbursement. We reviewed the availability of, and national cr...
Gastroenterology and hepatology
- 2018 •
- Jimp •
- Odkaz
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
News in the treatment of hepatitis C
Treatment of chronic hepatitis C is undergoing extraordinary changes in the past 4 years. Direct-Acting Antivirals (DAA) are gradually introducing into routine clinical practice either in combination with pegylated...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2015 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Role of general practitioner in the care of patients with chronic hepatitis C
Chronic hepatitis C therapy using directly acting antivirals (DAA) has high efficacy (till 100 %), minimum contra-indications and extraordinarily favorable safety profile. Current possibilities of interferon-free therapy re...
Infectious Diseases
- 2018 •
- Jost
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Hepatitis C – possible courses of the disease, importance of therapy and effects of untreated infection.
with directacting antivirals (DAAs) must be offered without delay to all persons with recently as undetectable HCV RNA in peripheral blood 12 or 24 weeks after the end of antiviral treatment. Regimens using DAAs e...
Infectious Diseases
- 2024 •
- Jost •
- Odkaz
Rok uplatnění
Jost - Ostatní články v recenzovaných periodicích
Výsledek na webu
IL28B genotyping and treatment of HCV infected subjects
acting antivirals (DAAs) are hopeful, as shown in many recent clinical studies, and triple therapy regimens involving DAA are becoming the new standard of care......
FP - Ostatní lékařské obory
- 2014 •
- Jx •
- Odkaz
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Výsledek na webu
New antivirotics in the treatment of hepatitis C
Treatment of chronic hepatitis C is undergoing extraordinary changes in the past 3 years. Direct-Acting Antiviral Agents (DAAs) are gradually introducing into routine clinical practice either in combination with pe...
FN - Epidemiologie, infekční nemoci a klinická imunologie
- 2014 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
- 1 - 10 z 71 913